This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease.
This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. Aronne, MD Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients Jay H.
Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.
The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.
Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.
A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. National Institute of Diabetes and Digestive and Kidney Diseases.
This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D., billion (2).
In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.
Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. These conditions affect a patient’s risk of health conditions like heart disease, diabetes, and obesity. ” “But,” cautions Dr.
She is one of the first fellowship-trained obesity medicine physicians in the world. She researches strategies to treat diabetes mellitus and reduce the risk of cardiovascular, renal, and other diabetes-related complications. Dr. Stanford has served as a health communications fellow for the U.S.
However, recent studies have observed that people below 40 are also experiencing heart attacks due to high blood pressure, cholesterol, diabetes, smoking, obesity, a sedentary lifestyle, and social and mental stress. Obesity or being overweight can increase the risk of heart disease. Manage diabetes.
As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity.
From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Eversense’s 365-day CGM and Medtronic’s Simplera Sync were among the major highlights, offering patients with diabetes more comfortable, longer-lasting monitoring options.
Quantitative RT-PCR was used to quantify mtDNA-CN and mtDNA4977 deletion rate.ResultsThe EOCAD group had a higher prevalence of male gender (p<0.001), smoking (p=0.001), hypertension (p<0.001), diabetes mellitus (p=0.04) and obesity (p<0.001) than controls.
Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,
In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content